Application of ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot resistance

By cloning and overexpressing the ginseng transcription factor PgJAZ13 gene in tobacco, the expression of disease-resistant genes and key enzymes of terpene synthesis was improved, and the problem of insufficient resistance to tobacco red star disease was solved, thereby enhancing tobacco disease resistance and avoiding chemical pesticides The effect of pollution.

CN119040344AActive Publication Date: 2024-11-29CENT SOUTH UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411329923.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-11-29
Estimated Expiration
2044-09-24

AI Technical Summary

Technical Problem

Tobacco red star disease causes serious damage to tobacco leaves, and the prior art is difficult to effectively improve the resistance of tobacco to the disease, and the use of chemical pesticides leads to food safety and environmental pollution problems.

Method used

By cloning the ginseng transcription factor PgJAZ13 gene and introducing it into tobacco through Agrobacterium-mediated transformation methods, the corresponding plant expression vector is constructed, the expression levels of relevant disease-resistant genes and key enzymes of terpene synthesis are improved, and the resistance of tobacco is enhanced Ability to illness.

Benefits of technology

It significantly improves the resistance of tobacco to red star disease, promotes the biosynthesis of disease-resistant proteins and terpenes, enhances the disease resistance of plants, and avoids environmental and food safety issues caused by the use of chemical pesticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005056542330000041
    Figure BDA0005056542330000041
  • Figure BDA0005056542330000042
    Figure BDA0005056542330000042
  • Figure BDA0005056542330000051
    Figure BDA0005056542330000051
Patent Text Reader

Abstract

The invention belongs to the field of biological gene engineering, and relates to application of a ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot resistance, and the sequence of the PgJAZ13 gene is as shown in SEQ ID NO.2. According to the invention, a PgJAZ13 gene is cloned, and a corresponding plant expression vector is constructed. Through an agrobacterium tumefaciens-mediated transformation method, the gene is successfully transferred into wild tobacco leaves, and a positive tobacco plant with stable overexpression of the PgJAZ13 gene is screened out. Experiments prove that the heterologous overexpression of the PgJAZ13 gene in tobacco can obviously improve the expression level of genes related to disease resistance and terpene synthesis key enzyme genes, so that the biosynthesis of disease-resistant proteins and terpenes is promoted, and finally the disease resistance of plants is enhanced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biological gene engineering and relates to the application of ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot disease resistance. Background Art

[0002] JAZ proteins play an important role in the response to biotic and abiotic stresses. In soybean, overexpression of GmTIFY10e and GmTIFF10g (homologs of AtJAZ1 and AtJAZ2 in Arabidopsis) increased proline content and POD and CAT enzyme activities, reduced malondialdehyde content, and led to changes in the expression of genes related to the ABA signaling pathway, thereby enhancing salt tolerance. [1] In cotton, overexpression of the GhJAZ2 gene reduces the sensitivity of plants to jasmonic acid (JA) and decreases the expression of the JA-responsive genes GhPDF1.2 and GhVSP, thereby increasing the susceptibility of plants to Verticillium dahliae and insect herbivory. [2] However, the functions of JAZ proteins in ginseng have not been fully elucidated.

[0003] Tobacco brown spot is a fungal plant disease that mainly affects tobacco leaves. It is caused by Alternaria alternate and causes serious damage to the quality of tobacco leaves. [3] . Leaves are the main site of the disease. In the early stages of the disease, the disease manifests itself as yellow-brown spots, which often form concentric ring-shaped lesions on the leaves. When the disease is severe, these concentric ring-shaped lesions will connect and merge to form a continuous lesion area. In a dry environment, the lesion area may crack, causing the leaves to dry and break, significantly reducing the commercial value of tobacco leaves. [4] In view of the fact that the widespread use of chemical pesticides has gradually led to food safety and environmental pollution problems, the use of genetic engineering technology to cultivate transgenic plants with antibacterial and antifungal properties has become an economical and environmentally friendly strategy.

[0004] References:

[0005] [1] LIU YL, ZHENG L, JIN LG, et al. Genome-wide analysis of the soybeanTIFY family and identification of GmTIFY10e and GmTIFY10g response to saltstress[J]. Front Plant Sci, 2022,13:17.

[0006] [2]HE

[0007] [3]LAMONDIA J A.Outbreak of Brown Spot of Tobacco Caused byAlternaria alternata in Connecticut and Massachusetts[J].Plant Disease,2001,85(2):230.

[0008] [4]YAKIMOVA ET,YORDANOVA ZP,SLAVOV S,et al.Alternaria alternata ATtoxin induces programmed cell death in tobacco[J].J Phytopathol,2009,157(10):592-601. Summary of the invention

[0009] The purpose of the present invention is to provide an application of ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot disease resistance.

[0010] In order to achieve the above object, the technical solution adopted by the present invention is:

[0011] Application of ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot disease resistance, the sequence of the PgJAZ13 gene is shown in SEQ ID NO.2.

[0012] The sequence of the PgJAZ13 protein is shown in SEQ ID NO.1.

[0013] SEQ ID NO.1 is:

[0014] MSTSSVIVDSGKFSGLRTARSPADKSNFSQTCNLLSQYLKEKGTLGDLSLGMSSGFECNGMPEPFRRPATPQTAAATTMNLFPVAEKPVQGFGSIVSNQEVPAKSEPEAAQMTIFYGGQVIVFNDFPAEKAKEIMLLANKGNSPILNNLTQKPIDQPSNLIPSSPNVVPNFSNSIIQERAQRPPQPIVSDLPIARKASLTRFLEKRKDRITARAPYASPAAAPSKPAESKSWLGLAAQSPVKFESEL。

[0015] SEQ ID NO.2 is as follows:

[0016] .

[0017] The invention discloses an application of ginseng transcription factor PgJAZ13 in improving the expression level of at least one gene related to tobacco brown spot disease resistance, wherein the sequence of the PgJAZ13 gene is shown in SEQ ID NO.2.

[0018] In one preferred embodiment, the genes related to tobacco brown spot disease resistance include one or more of PR (1a, 1b, 1c, 4a, ob12), ERF5, LRR-RLK (1, 2), CIPK (1, 2), GsSRK (1, 2) and fungal cell wall decomposition-related genes Echit (3, B) and β-GLU (1, 2).

[0019] The invention discloses an application of ginseng transcription factor PgJAZ13 in improving the expression level of at least one key enzyme gene for terpene synthesis related to tobacco brown spot disease resistance, wherein the sequence of the PgJAZ13 gene is shown in SEQ ID NO.2.

[0020] In one of the preferred embodiments, the key enzyme genes for terpene synthesis related to resistance to brown star disease include one or more of 3-hydroxy-3-methylglutaryl-CoA synthetase, 3-hydroxy-3-methylglutaryl-CoA reductase, 1-deoxy-D-xylulose-5-phosphate synthase, 1-deoxy-D-xylulose-5-phosphate isomerase, farnesyl pyrophosphate synthase and squalene synthase 3.

[0021] The invention discloses an application of ginseng transcription factor PgJAZ13 in improving the expression level of at least one protein related to tobacco brown spot disease resistance, wherein the sequence of the PgJAZ13 gene is shown in SEQ ID NO.2.

[0022] The invention discloses an application of ginseng transcription factor PgJAZ13 in improving the expression level of at least one terpenoid substance related to tobacco brown spot disease resistance, wherein the sequence of the PgJAZ13 gene is shown in SEQ ID NO.2.

[0023] A plasmid overexpressing the PgJAZ13 gene.

[0024] In a preferred embodiment, the vector is digested by enzymes to obtain a digested vector, and the PgJAZ13 gene is connected to the digested vector.

[0025] In a preferred embodiment, the vector is pCAMBIA1301s plasmid.

[0026] A competent Agrobacterium cell overexpressing the PgJAZ13 gene.

[0027] In a preferred embodiment, the Agrobacterium competent cells are obtained by transforming the plasmid into DH5α competent cells.

[0028] The overexpression Agrobacterium competent cell is used for enhancing tobacco brown spot disease resistance, and the overexpression Agrobacterium competent cell overexpresses the PgJAZ13 gene.

[0029] A tobacco plant, wherein the overexpression plant overexpresses the PgJAZ13 gene.

[0030] The overexpressed tobacco brown spot disease resistance is significantly enhanced.

[0031] The invention clones the PgJAZ13 gene and constructs a corresponding plant expression vector. The gene is successfully transferred into wild-type tobacco leaves by an Agrobacterium-mediated transformation method. Beta-glucuronidase (GUS) staining technology and quantitative polymerase chain reaction (RT-qPCR) are used to identify the genomic DNA and transcribed mRNA levels to screen out positive tobacco plants that stably overexpress the PgJAZ13 gene.

[0032] The present invention relates to transcriptomic analysis of transgenic strains. The analysis results show that in tobacco strains overexpressing PgJAZ13, the "defense response" category is the most significant, followed by the "stress response" and "biostimulation response" categories identified by gene ontology (GO) enrichment analysis. Further, the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that the "plant hormone signal transduction" pathway is the most significant, and the enrichment of the "diterpenoid biosynthesis metabolism" pathway is observed.

[0033] Compared with the prior art, the present invention has the following beneficial effects:

[0034] Experiments have shown that heterologous overexpression of the PgJAZ13 gene in tobacco can significantly increase the expression levels of genes related to disease resistance and key enzyme genes for terpenoid synthesis, thereby promoting the biosynthesis of disease-resistant proteins and terpenes, and ultimately enhancing the plant's disease resistance. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 For subcellular localization analysis of PgJAZ13;

[0036] Figure 2 Identification of PgJAZ13 transgenic tobacco plants; Figure A: PCR identification of hygromycin gene in 35S::PgJAZ13 transgenic tobacco leaves; Lane 1: Marker 2000; Lanes 2-6: genomic DNA of transgenic lines (OE1, OE4, OE5, OE6 and OE9); Lane 7: positive control, empty vector plasmid; Lane 8: negative control, genomic DNA of wild-type line; Figure B: GUS staining signals of transgenic tobacco and wild-type leaves.

[0037] Scale bar = 1 mm;

[0038] Figure 3 RT-qPCR was used to detect the expression level of PgJAZ13 in WT and OE strains; NtEF1α was used as the internal reference gene, and the significant difference was analyzed by t test, *P<0.05, **P<0.01;

[0039] Figure 4Transcriptome analysis of transgenic tobacco overexpressing PgJAZ13; Figure A: Volcano plot of differential gene expression distribution; Figure B: Heat map of correlation coefficients between samples; Figure C: KEGG enrichment analysis of differential genes shows upregulated pathways; Figure D: KEGG enrichment analysis of differential genes shows downregulated pathways; Figure E: GO enrichment analysis of differential genes shows upregulated entries; Figure F: GO enrichment analysis of differential genes shows downregulated entries;

[0040] Figure 5 Expression analysis of key enzyme genes for terpenoid biosynthesis in transgenic tobacco overexpressing PgJAZ13; HMGS, 3-hydroxy-3-methylglutaryl-CoA synthetase; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; DXS, 1-deoxy-D-xylulose-5-phosphate synthase; DXR, 1-deoxy-D-xylulose-5-phosphate isomerase; FPS, farnesyl pyrophosphate synthase; SS3, squalene synthase 3; NtEF1α was used as the internal reference gene, and the significant difference was tested by t-test, *P<0.05, **P<0.01;

[0041] Figure 6 Expression analysis of disease resistance genes in transgenic tobacco overexpressing PgJAZ13; RT-qPCR was used to detect the expression levels of disease resistance-related genes in leaves of WT and OE4 / OE5 / OE6 lines; NtEF1α was used as the internal reference gene, and the t-test was used to test for significant differences, *P<0.05, **P<0.01;

[0042] Figure 7 PgJAZ13 can improve the resistance of transgenic tobacco to Alternaria alternata (A. alternata); disease symptoms of 30-day-old wild type (WT) and OE6 strains at 10 days after inoculation with Alternaria alternata; scale bar = 1 cm. DETAILED DESCRIPTION

[0043] Example 1

[0044] Construction of gene PgJAZ13 overexpression vector

[0045] 1.1 PCR amplification of target fragment

[0046] PrimeSTAR Max DNA Polymerase produced by Takara was used for PCR amplification. In addition, the primers were designed by Primer Premier 5.0 software and synthesized by Beijing Qingke Biotechnology Co., Ltd. The primer sequences are as follows: Primer Sequence (5′→3′)

[0047] PgJAZ13+GFP-F: cgggggactgagctcggtaccATGTCCACCTCGTCGGTAATTG (SEQ IDNO.3)

[0048] PgJAZ13+GFP-R: gctcaccatgtcgactctagaCAATTCGCTTTCAAACTTGACTGG (SEQ ID NO. 4).

[0049] The cDNA template was obtained by reverse transcription of total RNA from ginseng callus tissue. The kits for RNA extraction and reverse transcription were: High-purity total RNA rapid extraction kit: Beijing Biotech Biotechnology Co., Ltd.; RP1202; Trizol: Vazyme catalog number: R401-01; reverse transcription kit: HiScript II 1st Strand cDNA Synthesis Kit (+gDNAwiper): R212-01.

[0050] The reaction system is as follows:

[0051] Table 1 PCR amplification system

[0052]

[0053] The PCR reaction program was set up as follows:

[0054] Table 2 PCR reaction procedure

[0055]

[0056] After the reaction was terminated, the liquid on the wall of the test tube was collected by instant centrifugation and then placed on ice for the next agarose gel purification step or temporarily stored in a -20°C refrigerator.

[0057] 1.4 PCR product purification and expression vector linearization

[0058] The PCR product was subjected to gel electrophoresis to remove non-specific amplification bands, and the target DNA fragment was purified using a gel recovery kit from Vazyme. The PCR product was mixed with 6 times the loading buffer and electrophoresed on an agarose gel for 30 minutes. Under ultraviolet light, the agarose gel area containing the target size DNA fragment was accurately cut and placed in a clean 1.5 ml centrifuge tube. The gel was then weighed, and subsequent steps were performed according to the instructions for use of the kit. The final DNA solution was tested for concentration and quality using an ultra-micro spectrophotometer and then stored in a -20°C refrigerator.

[0059] The expression vector was cut with BamHI and KpnⅠ restriction endonucleases, and the same gel recovery experiment was performed. The construction method of pCAMBIA1301s-GFP plasmid refers to the prior art (JIANG T, ZHANG Y, ZUO GG, et al. Transcription factor PgNAC72 activates DAMMARENEDIOL SYNTHASE expression to promote ginseng saponin biosynthesis [J]. Plant Physiology, 2024, 195 (4): 2952-2969.).

[0060] The enzyme digestion system is as follows:

[0061] Table 3 Endonuclease reaction system

[0062] 1.5 Vector ligation and E. coli transformation

[0063] The homologous recombination reaction is as follows:

[0064] Table 4 Homologous recombination reaction system

[0065]

[0066] After gently mixing with a micropipette, place the sample in a PCR instrument and set it to 37°C for incubation for 30 minutes. After the reaction is completed, take it out immediately and place it on ice, and then perform the E. coli transformation experiment. The specific steps are as follows:

[0067] (1) Take out a DH5α competent cell stored in a -80°C refrigerator, quickly transfer it to ice, and thaw it in ice for 10 minutes. Then, add 10 μL of the ligation product to the competent cell, mix well, and then let it stand on ice for 15 minutes.

[0068] (2) Place the centrifuge tube in step (1) in a 42°C water bath for 1 minute of heat shock treatment, then quickly move to ice and place on ice for 2 minutes.

[0069] (3) Add 700 μL of LB liquid medium without resistance to the centrifuge tube, shake gently to mix, and then perform shaking culture at 37°C and 200 rpm for 60 minutes.

[0070] (4) Centrifuge at 1,0000 × g for 1 minute to collect the cells, remove 700 μL of the supernatant, and resuspend the cells in the remaining approximately 100 μL of culture medium. After thorough pipetting and mixing, inoculate the culture medium onto LB solid culture medium containing 100 mg / L kanamycin (Kan), spread it evenly using a spreader, and incubate it in a 37°C constant temperature incubator for 12 hours.

[0071] The LB medium formula is as follows (volume 1 L):

[0072] Table 5 LB medium formula

[0073]

[0074] To prepare LB solid medium, add 15 g / L agar powder to the liquid medium, then autoclave at 121°C for 15 minutes. After sterilization, add the appropriate amount of antibiotics when the autoclaved medium cools to about 60°C. The medium can be stored for one week at room temperature.

[0075] 1.6 Identification of positive clones

[0076] Select 4 single colonies of appropriate size and inoculate them into 200 μL LB liquid culture medium containing 100 mg / L Kan. Perform shaking culture at 37°C and 200 rpm for 4 hours, and then take an appropriate amount of bacterial liquid for PCR identification. The configured reaction system is as follows:

[0077] Table 6 Bacterial liquid PCR reaction system

[0078]

[0079] The PCR reaction procedure is as follows:

[0080] Table 7 Bacterial liquid PCR reaction program

[0081]

[0082] The PCR products were analyzed by agarose gel electrophoresis to verify whether the obtained bands were single and whether their sizes were consistent with expectations. If the identification results of the PCR products were correct, the corresponding bacterial samples were sent to Beijing Qingke Biotechnology Co., Ltd. for DNA sequencing. After the sequencing results were correct, the remaining bacterial solution was expanded and cultured. Subsequently, 300 μL of fresh bacterial solution was taken and mixed with 700 μL of sterile glycerol, quickly frozen in liquid nitrogen, and stored in a -80°C refrigerator.

[0083] 1.7 Plasmid extraction

[0084] Adopt Beijing Qingke Biotechnology Co., Ltd. Plasmid Mini Kit is used to extract plasmid DNA. All steps are performed at room temperature:

[0085] (1) Take 4 mL of overnight culture and centrifuge at 12,000 × g for 1 min to collect the cells and discard the supernatant as much as possible;

[0086] (2) Add 250 μL of Buffer PA containing RNase A to the bacteria and mix by pipetting until no obvious bacterial clumps remain;

[0087] (3) Add 250 μL of Buffer PB and gently invert 6-8 times to fully lyse the cells.

[0088] (4) Add 350 μL of Buffer PC and gently invert 6-8 times to mix thoroughly. Centrifuge at 12,000 rpm for 10 min.

[0089] (5) Transfer the supernatant to the adsorption column, being careful not to aspirate the precipitate, centrifuge at 12,000 rpm for 1 min, discard the filtrate, and return the adsorption column to the collection tube;

[0090] (6) Add 600 μL of Buffer PW containing anhydrous ethanol along the wall of the adsorption column, centrifuge at 12,000 rpm for 1 min, discard the waste liquid, and repeat this step once;

[0091] (7) Place the adsorption column back into the collection tube and centrifuge the empty tube at 12,000 rpm for 2 min;

[0092] (8) Place the adsorption column in a new, clean 1.5 mL centrifuge tube, open the tube cap, and leave at room temperature for 2 min to evaporate the residual ethanol;

[0093] (9) Add 35-50 μL of Elution Buffer preheated to 60°C to the center of the adsorption membrane, let stand at room temperature for 2 min, and centrifuge at 12,000 rpm for 2 min. The resulting plasmid solution was stored in a -20°C refrigerator.

[0094] Example 2

[0095] Subcellular localization analysis of PgJAZ13

[0096] 2.1 Preparation of Agrobacterium chemically competent cells

[0097] (1) Take out the GV3101 / LB4404 strain (purchased from Shanghai Weidi Biotechnology Co., Ltd.) from the -80℃ freezer and place it in liquid nitrogen for rapid freezing protection. Then use an inoculation loop to take an appropriate amount of bacterial liquid and spread it on the YEB solid medium supplemented with Rif (50μg / mL) to recover the strain. After that, invert and culture it in a constant temperature incubator at 28℃ for 36 hours. The following is the formula of YEB medium:

[0098] Table 8 YEB medium formula

[0099]

[0100] When preparing YEB solid medium, add 15g / L agar powder according to the recipe and sterilize by autoclave at 121℃ for 15 minutes. Add antibiotics after the medium is cooled to about 50℃ and can be stored at room temperature for one week.

[0101] (2) Select a single colony of appropriate size, inoculate it into 5 mL of YEB liquid culture medium containing Rif (50 μg / mL), and culture it at 28°C and 200 rpm with shaking overnight.

[0102] (3) Inoculate 50 μL of the overnight culture into 50 mL of fresh YEB liquid medium and culture at 28°C and 200 rpm until the OD of the culture reaches 0. 600 The value reached about 0.6 to 0.8. Subsequently, the bacterial solution was transferred to a 50 mL sterile centrifuge tube and placed in an ice bath for 30 minutes.

[0103] (4) Place the centrifuge tube in a 4°C precooled centrifuge and centrifuge at 4,000 rpm for 10 minutes.

[0104] (5) Remove the supernatant and add 10 mL of pre-cooled 0.15 M NaCl solution to the precipitate. Gently pipette on ice to resuspend the bacterial solution, and then centrifuge at 4°C, 4,000 rpm for 10 min.

[0105] (6) After removing the supernatant, add 1 mL of pre-cooled 20 mM CaCl2 solution to the precipitate and gently pipette on ice to resuspend the bacterial solution. Then, divide the bacterial solution into pre-cooled 1.5 mL sterile centrifuge tubes, quickly freeze them with liquid nitrogen, and store them at -80°C for later use.

[0106] 2.2 Transformation of Agrobacterium competent cells

[0107] (1) Take out a GV3101 / LB4404 competent cell from a -80°C freezer and thaw it on ice for 10 minutes. In a clean bench, add 2 μL of the plasmid extracted in Example 1 to the bacterial solution, pipette gently to mix, and then let it stand on ice for 30 minutes.

[0108] (2) Quickly freeze in liquid nitrogen for 2-5 minutes, then heat shock in a 37°C water bath for 5 minutes. In an ultra-clean workbench, add 900 μL YEB liquid culture medium, then slowly shake at 28°C, 100 rpm to revive the cells for 4-6 hours.

[0109] (3) Centrifuge at 8,000 rpm for 1 minute, remove 800 μL of supernatant, and use the remaining culture medium to resuspend the bacteria. Spread the resuspended bacterial solution evenly on the surface of YRK (YEB containing 50 mg / L Rif and 50 mg / L Kan) solid culture medium, and then incubate inverted in a 28°C incubator for 2 days.

[0110] (4) Pick a single colony for bacterial liquid PCR identification, the method is the same as that in Example 1, select a positive colony for expansion culture, and then carry out the next step of genetic transformation or strain preservation.

[0111] 2.3 Tobacco cultivation

[0112] (1) Wild-type Nicotiana benthamiana seeds were placed in 1% sodium hypochlorite for oscillation sterilization for 10 minutes, then rinsed with sterile water 6 times to remove residual sodium hypochlorite, and the sterile seeds were transferred to solid MS medium and cultured at 28° C., 16 hours of light / 8 hours of darkness for 5-7 days until the seedling stage. The formula of MS medium is as follows:

[0113] Table 9 Formula of MS medium

[0114]

[0115] Adjust the pH to 5.8, add 8 g / L agar powder, and sterilize by high pressure at 121°C for 15 min.

[0116] (2) The tobacco seedlings were transferred to soil and continued to grow at 28°C, 16 h light / 8 h dark conditions until 3-4 strong leaves were grown.

[0117] 2.4 Activation and expansion of Agrobacterium GV3101

[0118] (1) The constructed recombinant Agrobacterium strain was inoculated into YRK liquid culture medium and cultured under shaking conditions of 28° C. and 200 rpm for about 36 hours.

[0119] (2) Pick a single colony and inoculate it into 3 mL of YRK liquid culture medium. Incubate the culture overnight at 28°C and 200 rpm with shaking.

[0120] (3) Take 200 μL of bacterial solution and add it to 5 mL of YRK medium containing 10 mM MES (pH = 5.6) and 200 μM AS. Cultivate at 28°C and 200 rpm until OD600 = about 1.5.

[0121] (4) Centrifuge at 5000 × g for 10 min, discard the supernatant, resuspend the cells with an equal volume of 10 mM MgCl2 solution, then add 200 μM AS and incubate in the dark for 3 h.

[0122] 2.5 Tobacco transient transformation

[0123] The pCAMBIA1301s-JAZ-GFP vector was transformed into Agrobacterium GV3101. The transformation method is detailed in 2.2. The epidermal cells under the tobacco leaves were infected by injection penetration, and three tobacco leaves were infected in each sample group. Two days after injection, 0.5 cm × 0.5 cm tobacco leaf samples were cut and immersed in DAPI staining solution, and incubated at room temperature for 10 minutes. A 10 ml syringe was used to draw a vacuum, and then the sample was placed under a laser confocal scanning microscope (LSM880; ZEISS) for observation of fluorescence signals.

[0124] like Figure 1 As shown in the figure, in the control experiment, that is, in the sample containing only the 35S-GFP empty vector, the GFP signal was observed to be distributed in the cytoplasm and the nucleus. However, in the experimental group containing the PgJAZ13-GFP fusion protein, the fluorescent signal was specifically localized in the nucleus, which indicates that PgJAZ13 is a nuclear transcription factor.

[0125] Example 3 Construction of transgenic tobacco overexpressing PgJAZ13

[0126] To construct tobacco plants that stably overexpress PgJAZ13, Agrobacterium tumefaciens LB4404 carrying the pCAMBIA1301s-35s-PgJAZ13 plasmid was used to infect common tobacco. The specific experimental method is as follows:

[0127] 3.1 Preparation of tobacco culture medium

[0128] Prepare the culture medium required for the experiment in advance. After preparing according to the formula, sterilize at 121℃ for 25min, add antibiotics after cooling to 60℃, and then divide for use. The culture medium and formula involved are as follows:

[0129] Table 10 Formula of culture medium used for transgenic tobacco construction

[0130]

[0131] 3.2 Tobacco pre-cultivation

[0132] Common tobacco (Nicotiana tabacum Xanthi) was used, and the pre-culture method was the same as in Example 2, until 6 true leaves grew. 3.3 LB4404 Agrobacterium Activation

[0133] (1) Take out the recombinant Agrobacterium tumefaciens LB4404 carrying the pCAMBIA1301s-PgJAZ13-GFP plasmid from the -80°C refrigerator, gently scrape part of the bacteria using an inoculation loop in the clean bench, and inoculate into 3 mL of YEB liquid medium containing Sm (125 μg / mL) and Kan (50 μg / mL) resistance. Incubate at 28°C, 200 rpm, shaking overnight;

[0134] (2) Secondary activation: inoculate the overnight bacterial solution into a new YEB liquid medium with the same resistance, and culture at 28°C and 200 rpm until the OD is 0.8-1.2. Do not over-culture (about 16 h to 24 h);

[0135] (3) Collecting bacteria: centrifuge at room temperature and 8000 rpm for 1 min to collect bacteria;

[0136] (4) Resuspend the cells in a liquid co-culture medium containing AS (100 μM) at an equal volume ratio of 1:1, and place the resuspended bacterial solution on a shaker (100-110 rpm) for about 30 min in the dark.

[0137] 3.4 Tobacco genetic transformation

[0138] (1) Cut tobacco leaves into 5×5 mm leaf discs, taking care to avoid leaf veins and leaf edges as much as possible;

[0139] (2) Transfer the leaf disc to the resuspended bacterial solution and infect on a shaker (100-110 rpm) for 45-60 min;

[0140] (3) Discard the bacterial solution, spread the leaf discs on the co-culture plate, and culture in the dark for 48 h;

[0141] (4) Transfer to screening medium (28°C, 16 h light culture / 8 h dark culture) and culture for about two weeks;

[0142] (5) After callus tissue grows on the leaf disc, transfer it to a budding medium and culture it for about 3 weeks. After leaf buds appear on the leaf disc, cut off the leaf buds and transfer them to a rooting medium for culture until the seedlings grow;

[0143] (6) Transplanting the seedlings into nutrient pots to obtain five transgenic lines: OE1, OE4, OE5, OE6, and OE9.

[0144] 3.5 Identification of transgenic tobacco by GUS staining

[0145] pCAMBIA1301s-GFP is a plasmid with the β-D-glucuronidase (GUS) gene, and there is no endogenous GUS gene in tobacco. Using Coolaber's GUS staining kit, transgenic tobacco leaves were taken for GUS staining identification to detect whether the pCAMBIA1301s-PgJAZ13-GFP plasmid is stably expressed in tobacco cells.

[0146] 3.6 PCR identification of transgenic tobacco

[0147] (1) Extraction of genomic DNA from transgenic tobacco

[0148] The transgenic tobacco gDNA was extracted using the Steady Pure Plant Genomic DNA Extraction Kit from Acryl. For detailed experimental steps, please refer to the kit manual.

[0149] (2) PCR verification, the primer sequences are as follows:

[0150] Primer Sequence (5′→3′)

[0151] Hyg-F: ACACTACATGGCGTGATTTCAT(SEQ ID NO.5)

[0152] Hyg-R:TCCACTATCGGCGAGTACTTCT(SEQ ID NO.6)

[0153] Table 11 PCR identification reaction system

[0154]

[0155] The reaction conditions are the same as in Example 1.

[0156] The PCR products were collected for agarose gel electrophoresis, and photos were taken using the ChemiDoc XRS gel imager from Bio Rad.

[0157] like Figure 2 As shown in A, the five transgenic lines (OE1, OE4, OE5, OE6, and OE9) all showed a blue staining reaction unique to GUS enzyme activity, among which the OE6 line showed significant GUS enzyme activity. Figure 2 As shown in Figure B, the genomic DNA was amplified and verified by PCR using specific primers containing the hygromycin resistance gene selection marker (SEQ ID NO.5 and SEQ ID NO.6). The results showed that all transgenic positive plants produced an amplified band with the expected size of 550 bp, while the corresponding amplified fragment was not detected in the wild-type plants.

[0158] Example 4

[0159] Detection of PgJAZ13 gene expression in transgenic lines

[0160] 4.1 Total RNA extraction from tobacco leaf tissue

[0161] (1) Add 1 ml of Trizol to an RNase-Free centrifuge tube and place it on ice. Grind the sample into powder using a mortar and pestle. During this process, liquid nitrogen needs to be continuously added to the mortar. Add 50 mg of powder to a centrifuge tube and mix well using a vortexer. Let stand at room temperature for 5 minutes.

[0162] (2) Centrifuge at 12,000 × g for 5 min at 4°C. Carefully pipette 950 μL of the supernatant into a new RNase-free centrifuge tube. Add chloroform (1 / 5 the volume of Trizol) and mix thoroughly. Let stand at room temperature for 5 min.

[0163] (3) Centrifuge at 12,000 × g for 10 min at 4°C. The homogenate will separate into three layers: the supernatant containing RNA, the middle protein layer, and the lower organic phase.

[0164] (4) Transfer 450ul of supernatant to another new RNase free centrifuge tube (do not aspirate the intermediate protein layer); add 450uL of isopropanol equal to the volume of Trizol, mix thoroughly, and let stand at room temperature for 10min;

[0165] (5) The mixture was transferred to an adsorption column RA, centrifuged at 13,000 rpm for 2 min, and the filtrate was discarded;

[0166] (6) Add 500 μL of deproteinized solution RW1, place at room temperature for 3 min, centrifuge at 13,000 rpm for 30 s, and discard the filtrate;

[0167] (7) Add 500 μL of rinsing solution RW pre-added with anhydrous ethanol, centrifuge at 13,000 rpm for 30 s, and discard the filtrate; repeat this operation once;

[0168] (8) Place the adsorption column back into the empty collection tube and centrifuge at 13,000 rpm for 2 minutes;

[0169] (9) Place the adsorption column in a new RNase-free centrifuge tube, open the lid and leave it at room temperature for 2 min to evaporate the residual ethanol; add 30 μL of RNase-free water preheated to 70-90°C to the adsorption membrane, leave it at room temperature for 2 min, and centrifuge at 12,000 rpm for 1 min.

[0170] Take 2 μL of the RNA and use it for agarose gel electrophoresis to evaluate the integrity of the RNA. The unused RNA sample should be stored in a -80℃ refrigerator for subsequent reverse transcription or other purposes.

[0171] 4.2 Reverse transcription synthesis of first-strand cDNA

[0172] (1) Removal of genomic DNA

[0173] In a 0.2 mL PCR tube free of RNase contamination, add the following reagents in order:

[0174] Table 12 Reverse transcription reaction system

[0175]

[0176] After mixing the above reagents, incubate the sample at 42°C for 2 minutes in a PCR instrument, then take it out and immediately place it on ice for subsequent use.

[0177] (2) Synthesis of the first strand of cDNA

[0178] Add 4 μL of 5×HiScriptⅡEnzyme Mix to the PCR tube containing the above reaction solution, and perform the following reaction program in the PCR instrument: 50℃, 15min; 85℃, 5s. After the reaction is completed, the synthesized cDNA sample is diluted 10 times and stored in a -20℃ refrigerator.

[0179] 4.3 RT-qPCR analysis

[0180] RT-qPCR analysis was performed using the ChamQ Universal SYBR qPCR Master Mix (Q711-02) kit from Novozymes, and the system was as follows:

[0181] Table 13 RT-qPCR reaction system

[0182]

[0183] The amplification procedure is as follows:

[0184] Table 14 RT-qPCR reaction procedure

[0185]

[0186] PgACT was used as the internal reference gene, and each sample was tested in triplicate. -ΔΔCt The method is used to measure the relative differences in gene transcription levels and analyze and compare the expression levels of individual genes based on this.

[0187] The primer sequences used are as follows:

[0188] Primer Sequence (5′→3′)

[0189] qRT-PgJAZ13-F:TTACGGCGGTCAAGTCATC (SEQ ID NO.7);

[0190] qRT-PgJAZ13-R:GAGGGAATCAAATTGGAAGG (SEQ ID NO. 8).

[0191] like Figure 3 As shown, analysis of the five transgenic lines showed that the expression level of the PgJAZ13 gene in the OE6 line was significantly higher than that in the other lines.

[0192] Example 5

[0193] Transcriptomic analysis of transgenic tobacco overexpressing PgJAZ13

[0194] 5.1 Library construction and sequencing

[0195] In this experiment, leaf tissue samples of transgenic line OE-6 and wild-type control (WT) tobacco were collected. These samples were from three independent biological replicates and used for subsequent RNA extraction. The total RNA of the extracted samples was quality tested and analyzed using a NanoDrop micro-volume UV spectrophotometer and an Agilent 2100 bioanalyzer. Subsequently, 3 μg of total RNA from each sample was used to construct a cDNA library. These libraries were sequenced using the MGISEQ-T7 sequencing platform using a PE150 read length. In order to obtain clean reads suitable for subsequent analysis, the adapter sequences and low-quality reads were removed. Finally, the clean reads were aligned with the tobacco reference genome sequence using the HISAT2 software.

[0196] 5.2 RNA-seq data analysis

[0197] The featureCounts software was used to calculate the number of aligned fragments per million (FPKM) of each gene in each sample. The DESeq2 software was used to analyze the differences in gene expression between samples, and the screening criteria for differentially expressed genes were set as log2FC absolute value>1 and P-adjusted value<0.05. The detected differentially expressed genes (DEGs) were compared with each classification entry in the GO database, and the number of genes in each classification was counted. Then, the significance of protein enrichment in specific GO functional entries was evaluated by Fisher's exact test, and the threshold q value was set ≤0.05 to identify significantly enriched functional annotation GO entries. At the same time, the KEGG public database was used to perform functional annotation and significant enrichment analysis of DEGs, and the threshold q value was set ≤0.05.

[0198] like Figure 4 (A, B), A total of 6485 differentially expressed genes (DEGs) were identified between OE6 and WT lines, of which 2783 were upregulated and 3702 were downregulated in OE6. The correlation between OE6 and WT samples was very low (r 2 =0.25). KEGG enrichment analysis and GO enrichment analysis were then performed on DEGs between OE6 and WT lines.

[0199] like Figure 4 (C, D), in the enrichment analysis of KEGG pathway information of 6485 DEGs, "plant hormone signal transduction" became the most important pathway category, which is consistent with the key involvement of JAZ proteins in the jasmonic acid signaling pathway. It was also observed that the diterpenoid biosynthesis metabolism pathway was also enriched. In contrast, the fatty acid elongation and steroid hormone biosynthesis pathways were downregulated. These results suggest that PgJAZ13 may regulate the biosynthesis metabolism of terpenoids.

[0200] like Figure 4 (E, F), GO enrichment analysis of 6485 DEGs, the top 20 most significant GO functional entries are shown in the figure. Among the up-regulated functional entries, "defense response" was the most significant, followed by "stress response" and "biological stimulus response". In contrast, genes related to amino acid metabolism in the OE6 line were down-regulated. These results indicate that overexpression of PgJAZ13 in tobacco may affect the expression of genes related to pathogen resistance.

[0201] Example 6

[0202] Detection of the expression of disease resistance genes and key enzyme genes for terpenoid synthesis in transgenic lines

[0203] The experimental steps of tobacco leaf RNA extraction, reverse transcription, RT-qPCR analysis, etc. refer to Example 4.

[0204] Entertainment:

[0205] Primer Sequence(5′→3′)

[0206] NtEF1α-F:TGAGATGCACCACGAAGCTC(SEQ ID NO.9)

[0207] NtEF1α-R:CCAACATTGTCACCAGGAAGTG(SEQ ID NO.10)

[0208] NtHMGS-F:AACCGGCCACATTAATACCA(SEQ ID NO.11)

[0209] NtHMGS-R:TCACAAAGTCCTTACCACCA(SEQ ID NO.12)

[0210] NtHMGR-F:TTGAGGATGAAAACGATGAG(SEQ ID NO.13)

[0211] NtHMGR-R:ATTCCAAAGAGTATGACGGC(SEQ ID NO.14)

[0212] NtDXS-F:CTGCCATTGATGACAGACCA(SEQ ID NO.15)

[0213] NtDXS-R:AGCAACATGAGACCCGAAAC(SEQ ID NO.16)

[0214] NtDXR-F:CAGCTACAACCTTAACCACC(SEQ ID NO.17)

[0215] NtDXR-R:TTCTCAGCGACTATATCCAA(SEQ ID NO.18)

[0216] NtFPS-F:AGGTGCTGGGTAAGATTGGC(SEQ ID NO.19)

[0217] NtFPS-R:ACACTGCTTGCACTGCTTTG(SEQ ID NO.20)

[0218] NtSS3-F:TGGGTGCAGGAATGGCAA(SEQ ID NO.21)

[0219] <h2 style=";text-align:left;direction:ltr">NtSS3-R:TTCTTTCCCAGAGGCGCG(SEQ ID NO.22)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0220] <h2 style=";text-align:left;direction:ltr"> NtPR1a-F:ACTCTTGCCGTGCCCAAA(SEQ ID NO.23)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0221] <h2 style=";text-align:left;direction:ltr"> NtPR1a-R:TGCTACCTGGTCGTCCCA(SEQ ID NO.24)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0222] <h2 style=";text-align:left;direction:ltr"> NtPR1b-F:GGGACAACGGGGTAGCAG(SEQ ID NO.25)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0223] <h2 style=";text-align:left;direction:ltr"> NtPR1b-R:GGCCTTAGCAGCCGTCAT(SEQ ID NO.26)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0224] <h2 style=";text-align:left;direction:ltr"> NtPR1c-F:TGGGACGACCAGGTAGCA(SEQ ID NO.27)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0225] <h2 style=";text-align:left;direction:ltr"> NtPR1c-R:ATCGCCACTTCCCCAAGC(SEQ ID NO.28)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0226] <h2 style=";text-align:left;direction:ltr"> NtPR4a-F:GCACAGAGCGCCACAAAC(SEQ ID NO.29)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0227] <h2 style=";text-align:left;direction:ltr"> NtPR4a-R:GGCATCCCAAGTAGCGCA(SEQ ID NO.30)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0228] <h2 style=";text-align:left;direction:ltr"> NtPRob12-F:CTACACAGTCTGGGCCGC(SEQ ID NO.31)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0229] <h2 style=";text-align:left;direction:ltr"> NtPRob12-R:GACCCCAAATGCGAGCCT(SEQ ID NO.32)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0230] <h2 style=";text-align:left;direction:ltr"> NtEChiB-F:CGAGGATGGGCAACAGCA(SEQ ID NO.33)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0231] <h2 style=";text-align:left;direction:ltr"> NtEChiB-R:CCGACCAGGAGCACAAGG(SEQ ID NO.34)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0232] <h2 style=";text-align:left;direction:ltr"> NtEChit3-F:TGACAGAGCAGCGAACCG(SEQ ID NO.35)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0233] <h2 style=";text-align:left;direction:ltr"> NtEChit3-R:ACCCTAGCGTCAGAGCCA(SEQ ID NO.36)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0234] <h2 style=";text-align:left;direction:ltr"> NtERF5-F:GCGGCGGAAATTCGTGAC(SEQ ID NO.37)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0235] <h2 style=";text-align:left;direction:ltr"> NtERF5-R:ACGCCGCCCTGTCATATG(SEQ ID NO.38)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0236] <h2 style=";text-align:left;direction:ltr"> NtβGLU1-F:TGTTGCTCCTGCCATGCA(SEQ ID NO.39)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0237] <h2 style=";text-align:left;direction:ltr"> NtβGLU1-R:GGGCGGGTAGGTATTCGC(SEQ ID NO.40)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0238] <h2 style=";text-align:left;direction:ltr"> NtβGLU2-F:AGCAGCATCAGGGTTGCA(SEQ ID NO.41)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0239] <h2 style=";text-align:left;direction:ltr"> NtβGLU2-R:TGGGTGGGTAGGTGTTTGC(SEQ ID NO.42)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0240] <h2 style=";text-align:left;direction:ltr"> NtLRR-RLK1-F:GGGCGGTCCGTTCAAGAA(SEQ ID NO.43)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0241] <h2 style=";text-align:left;direction:ltr"> NtLRR-RLK1-R:AGTGGGGCATGGCAGAAC(SEQ ID NO.44)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0242] <h2 style=";text-align:left;direction:ltr"> NtLRR-RLK2-F:GTGCAACCTCGTCGGACC(SEQ ID NO.45)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0243] <h2 style=";text-align:left;direction:ltr"> NtLRR-RLK2-R:GCGTTGCCATCCAGTGCT(SEQ ID NO.46)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0244] <h2 style=";text-align:left;direction:ltr"> NtCIPK1-F:CGGCAGAGTCCCCTGAGA(SEQ ID NO.47)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0245] <h2 style=";text-align:left;direction:ltr"> NtCIPK1-R:ACCTCCGCCAGAAGCCTA(SEQ ID NO.48)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0246] <h2 style=";text-align:left;direction:ltr"> NtCIPK2-F:AGGAAGTGGCGAAGACGAC(SEQ ID NO.49)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0247] <h2 style=";text-align:left;direction:ltr"> NtCIPK2-R:TCTCCCACTCTCTTGCCCT(SEQ ID NO.50)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[0248] NtGsSRK1-F: TGTCGGCGGAAGTGTGTC (SEQ ID NO.51)

[0249] NtGsSRK1-R:AACCTCCTCGTCCCCGAC (SEQ ID NO.52)

[0250] NtGsSRK2-F: TGGGTTGGGCATCTCCG (SEQ ID NO.53)

[0251] NtGsSRK2-R: ACCACTGGTTGCCTGCTC (SEQ ID NO.54)

[0252] like Figure 6 As shown, the expression levels of PR (1a, 1b, 1c, 4a, ob12), ERF5, LRR-RLK (1, 2), CIPK (1, 2), GsSRK (1, 2) and fungal cell wall decomposition-related genes Echit (3, B) and β-GLU (1, 2) in tobacco were significantly upregulated after PgJAZ13 overexpression. The results showed that the overexpression of PgJAZ13 in tobacco induced the expression of genes related to resistance to pathogens.

[0253] The experimental results of Example 5 showed that the diterpenoid biosynthesis metabolic pathway was significantly enriched. Based on this finding, the present invention further detected the expression levels of key enzyme genes in the terpenoid biosynthesis pathway in transgenic strains OE4, OE5, OE6 and wild-type control (WT). The operation steps refer to Example 4. Figure 5 As shown, overexpression of the PgJAZ13 gene significantly upregulated the expression of key enzyme genes for terpenoid synthesis, indicating that PgJAZ13 may play an important role in promoting the biosynthesis of terpenoids.

[0254] Example 7

[0255] Alternaria infection experiment

[0256] 7.1 Collection of Alternaria spores

[0257] (1) In a clean bench, inoculate Alternaria spores on PDA medium and culture it in a 28°C incubator. Culture it in the dark for about one week until the hyphae cover the entire medium.

[0258] (2) Prepare a spore suspension of Alternaria using 0.05% Tween-80 solution. Drop 3 mL of Tween-80 into the culture medium of Alternaria and gently scrape the spores using a triangular applicator;

[0259] (3) Filter through two layers of filter paper to remove the mycelium and collect the Alternaria spores. Dilute to a concentration of about 5×10 5 / mL. Note that the clean bench cannot be ventilated during the entire experimental process.

[0260] 7.2 Alternaria spores infecting tobacco leaves

[0261] (1) Select mature tobacco leaves and cover the petioles with soaked cotton wool to moisten the leaves. Use a syringe needle to make four symmetrical wounds and inoculate each wound with 50 μL of spore suspension. Place in an incubator at 28°C, 16 h light culture / 8 h dark culture;

[0262] (2) Observe the pathological status of tobacco leaves every day and keep the cotton wool moist;

[0263] (3) After 10 days, take photos of the lesions.

[0264] like Figure 7 As shown, compared with the wild type, the overexpression strain showed milder disease symptoms and the lesion area was significantly smaller than that of the wild type.

[0265] These results indicate that heterologous overexpression of the PgJAZ13 gene in tobacco can significantly increase the expression levels of genes related to disease resistance and key enzyme genes for terpenoid synthesis, thereby promoting the biosynthesis of disease-resistant proteins and terpenes, and ultimately enhancing the plant's disease resistance.

[0266] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the scope of protection of the invention.

Claims

1. Application of ginseng transcription factor PgJAZ13 in enhancing tobacco brown spot disease resistance, characterized in that: The sequence of the PgJAZ13 gene is shown in SEQ ID NO.

2.

2. The use of ginseng transcription factor PgJAZ13 in improving the expression level of at least one gene related to tobacco brown spot disease resistance, characterized in that: The sequence of the PgJAZ13 gene is shown in SEQ ID NO.

2.

3. The use according to claim 2, characterized in that: The genes related to tobacco brown spot disease resistance include one or more of PR (1a, 1b, 1c, 4a, ob12), ERF5, LRR-RLK (1, 2), CIPK (1, 2), GsSRK (1, 2) and fungal cell wall decomposition related genes Echit (3, B) and β-GLU (1, 2).

4. The use of ginseng transcription factor PgJAZ13 in improving the expression level of at least one key enzyme gene for terpene synthesis related to tobacco brown spot disease resistance, characterized in that: The sequence of the PgJAZ13 gene is shown in SEQ ID NO.

2.

5. The use according to claim 4, characterized in that: The key enzyme genes for terpene synthesis related to resistance to brown star disease include one or more of 3-hydroxy-3-methylglutaryl-CoA synthetase, 3-hydroxy-3-methylglutaryl-CoA reductase, 1-deoxy-D-xylulose-5-phosphate synthase, 1-deoxy-D-xylulose-5-phosphate isomerase, farnesyl pyrophosphate synthase and squalene synthase 3.

6. Use of ginseng transcription factor PgJAZ13 in increasing the expression level of at least one protein related to tobacco brown spot disease resistance, characterized in that: The sequence of the PgJAZ13 gene is shown in SEQ ID NO.

2.

7. Use of ginseng transcription factor PgJAZ13 in improving the expression level of at least one terpenoid substance related to tobacco brown spot disease resistance, characterized in that: The sequence of the PgJAZ13 gene is shown in SEQ ID NO.

2.

8. A plasmid, characterized in that The plasmid overexpresses the PgJAZ13 gene.

9. An Agrobacterium competent cell, characterized in that: The Agrobacterium competent cells overexpress the PgJAZ13 gene.

10. Use of the plasmid according to claim 8 or the Agrobacterium competent cell according to claim 9 in enhancing resistance to tobacco brown spot disease.

Citation Information

Patent Citations

  • Gene promoter of ginseng PgPDR3 responded by methyl jasmonate and application thereof

    CN103103194A

  • Lily transcription factor gene LrWRKY-L1 and application thereof

    CN111909941A